SEC Form 4 · accession 0001209191-18-061908
Sarepta Therapeutics, Inc. · SRPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mary Ann Gray
Director
Period of report
Dec 10, 2018
Accepted (ET)
Dec 11, 2018 · 8:38 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000873303
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F1 | $122.80 | Dec 10, 2018 | A | 5,711 | A | — | Dec 10, 2028 | Common Stock | 5,711 | 5,711 | D |
| Restricted Stock UnitsF2,F3 | — | Dec 10, 2018 | A | 2,901 | A | — | Dec 10, 2028 | Common Stock | 2,901 | 2,901 | D |
Explanation of responses
- F1The option vests in three equal annual installments beginning December 10, 2019, subject to continued service to the Board.
- F2Each restricted stock unit represents a contingent right to receive one share of Sarepta Therapeutics, Inc. common stock.
- F3The restricted stock units vest in three equal annual installments beginning December 10, 2019, subject to continued service to the Board.